LENZ (LENZ Therapeutics) EV-to-Revenue : (As of Dec. 15, 2024)

LENZ Therapeutics EV-to-Revenue Chart

LENZ Therapeutics Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EV-to-Revenue	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of LENZ Therapeutics's EV-to-Revenue

For the Biotechnology subindustry, LENZ Therapeutics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LENZ Therapeutics's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LENZ Therapeutics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where LENZ Therapeutics's EV-to-Revenue falls into.

LENZ Therapeutics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

LENZ Therapeutics's EV-to-Revenue for today is calculated as:

LENZ Therapeutics's current Enterprise Value is $636.17 Mil.
LENZ Therapeutics's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LENZ Therapeutics  (NAS:LENZ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

LENZ Therapeutics's PS Ratiofor today is calculated as:

LENZ Therapeutics's share price for today is $30.97.
LENZ Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LENZ Therapeutics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of LENZ Therapeutics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

LENZ Therapeutics Business Description